Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area
- PMID: 31361906
- DOI: 10.1111/his.13964
Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area
Abstract
Aims: Plasmablastic lymphoma (PBL) occurs mainly in immunocompromised individuals, usually secondary to human immunodeficiency virus (HIV) infection. It classically occurs intraorally, but has been described in extraoral locations. The aim of this study was to define the immunophenotype and Epstein-Barr virus (EBV) status in a large single-centre cohort of extraoral PBL (EPBL) in South Africa, a high-prevalence HIV setting.
Methods and results: This retrospective study of 45 EPBLs included patients' age, gender, race, HIV status, and site. Cases were reviewed histologically, and classified morphologically as pure plasmablastic or plasmablastic with plasmacytic differentiation, and assessed immunohistochemically with antibodies against CD45, CD20, CD79a, PAX5, CD138, MUM1/IRF4, BLIMP1, VS38c, Ki67, bcl-6, CD10, cyclin D1, and human herpesvirus-8, by the use of standard automated procedures. EBV was assessed by the use of chromogenic in-situ hybridisation. Tumours were assessed with a fluorescence in-situ hybridisation (FISH) MYC break-apart probe. Twenty-seven PBLs showed pure plasmablastic morphology, and 18 showed plasmacytic differentiation. The male/female ratio was 1.5:1. The anus was the favoured extraoral site (31.1%), followed by lymph nodes (15.6%). All 29 patients with known HIV status were HIV-positive. The immunohistochemical profile recapitulated that reported for oral PBLs and EPBLs in HIV-positive and HIV-negative patients. EBV was positive in 92.5% of PBLs. FISH analysis showed MYC rearrangement in 48% of cases.
Conclusion: This study showed a strong association of EPBLs with HIV and EBV infection, similarly to the previously described oral PBL. The strong EBV association together with other clinicopathological parameters and an immunohistochemical profile that includes CD45, CD20, MUM1/IRF4, CD138 and Ki67 may be used in distinguishing PBL from diffuse large B-cell lymphoma and plasma cell myeloma.
Keywords: EBV; HIV; diffuse large B-cell lymphoma; extraoral; oral; plasma cell myeloma; plasmablastic lymphoma.
© 2019 John Wiley & Sons Ltd.
Similar articles
-
Oral versus extra-oral plasmablastic lymphoma: A comparative analysis of 101 cases.J Oral Pathol Med. 2022 Feb;51(2):146-151. doi: 10.1111/jop.13269. Epub 2021 Dec 31. J Oral Pathol Med. 2022. PMID: 34910327
-
Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.Diagn Pathol. 2015 Jun 25;10:78. doi: 10.1186/s13000-015-0315-z. Diagn Pathol. 2015. PMID: 26108914 Free PMC article.
-
High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma.Histopathology. 2020 Jan;76(2):201-211. doi: 10.1111/his.13959. Epub 2019 Oct 13. Histopathology. 2020. PMID: 31348551
-
CD138- Plasmablastic Lymphoma: A Multi-institutional Study and Review of the Literature.Arch Pathol Lab Med. 2023 Jun 1;147(6):643-654. doi: 10.5858/arpa.2021-0462-OA. Arch Pathol Lab Med. 2023. PMID: 36161544 Review.
-
Plasmablastic lymphoma: An update.Int J Lab Hematol. 2022 Sep;44 Suppl 1(Suppl 1):54-63. doi: 10.1111/ijlh.13863. Int J Lab Hematol. 2022. PMID: 36074710 Free PMC article. Review.
Cited by
-
Epstein barr virus encodes miRNAs to assist host immune escape.J Cancer. 2020 Feb 3;11(8):2091-2100. doi: 10.7150/jca.42498. eCollection 2020. J Cancer. 2020. PMID: 32127936 Free PMC article. Review.
-
Heterogeneity in the diagnosis of plasmablastic lymphoma, plasmablastic myeloma, and plasmablastic neoplasm: a scoping review.Int J Hematol. 2021 Dec;114(6):639-652. doi: 10.1007/s12185-021-03211-w. Epub 2021 Aug 30. Int J Hematol. 2021. PMID: 34462886
-
The Prevalence of Epstein-Barr Virus in Plasma Cell Neoplasms is Higher in HIV-Positive Individuals.Int J Surg Pathol. 2023 Aug;31(5):564-571. doi: 10.1177/10668969221113490. Epub 2022 Aug 1. Int J Surg Pathol. 2023. PMID: 35912479 Free PMC article.
-
The genetic structure and adaptation of Andean highlanders and Amazonians are influenced by the interplay between geography and culture.Proc Natl Acad Sci U S A. 2020 Dec 22;117(51):32557-32565. doi: 10.1073/pnas.2013773117. Epub 2020 Dec 4. Proc Natl Acad Sci U S A. 2020. PMID: 33277433 Free PMC article.
-
Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway.Blood Cancer Discov. 2020 Jul;1(1):112-125. doi: 10.1158/2643-3230.BCD-20-0051. Blood Cancer Discov. 2020. PMID: 33225311 Free PMC article.
References
-
- Tchernonog E, Faurie P, Coppo P et al. Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group. Ann. Oncol. 2017; 28; 843-848.
-
- Campo E, Stein H, Harris NL. Plasmablastic lymphoma. In Swerdlow SH, Campo E, Harris NL eds. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon: IARC Press, 2017; 321-322.
-
- Brown NA, Elenitoba-Johnson KS. Update from the 4th Edition of the World Health Organization classification of head and neck tumours: hematolymphoid tumours. Head Neck Pathol. 2017; 11; 96-109.
-
- Alli N, Meer S. Head and neck lymphomas: a 20-year review in an Oral Pathology Unit, Johannesburg, South Africa, a country with the highest global incidence of HIV/AIDS. Oral Oncol. 2017; 67; 17-23.
-
- Rafaniello Raviele P, Pruneri G, Maiorano E. Plasmablastic lymphoma: a review. Oral Dis. 2009; 15; 38-45.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous